BridgeBio Oncology Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $54.1M | $52.7M | $373.7M | $408.7M | $31.7M | $26.3M | $30.9M | $20.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $242.4M | $266.5M | $432.4M | $476.0M | $876.8K | $1.2M | $158.7M | $2.0M |
| Property, Plant & Equipment | $878.0K | $938.0K | $956.0K | $827.0K | — | — | $490.0K | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $376.7M | $417.6M | $448.4M | $484.8M | $197.4M | $195.7M | $164.3M | $192.3M |
| Liabilities | ||||||||
| Accounts Payable | $6.7M | $12.1M | $1.4M | $3.7M | — | — | $3.1M | — |
| Total Current Liabilities | $51.6M | $43.3M | $35.0M | $35.7M | $2.6M | $1.9M | $19.6M | $126.7K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $53.6M | $45.4M | $37.3M | $38.1M | $8.1M | $7.4M | $19.6M | $5.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-455.1M | $-398.7M | $-356.6M | $-317.8M | $-7.3M | $-6.2M | $-222.5M | $-3.5M |
| Total Stockholders' Equity | $323.1M | $372.3M | $411.1M | $446.7M | $-227.7M | $-200.0M | $-178.6M | $-159.2M |